DUBLIN – Europe's bright start to the year continued, with two firms taking in more than €77 million (US$88.2 million) in oversubscribed public offerings on the Euronext Exchange Wednesday. Cell therapy developer Bone Therapeutics SA raised €32.2 million in an upsized IPO, while vaccines firm Valneva SE took in more than €45 million in a discounted follow-on offering, to fund its acquisition of the Dukoral oral vaccine against cholera and travelers' diarrhea.